TargEDys and Medical Foods just signed an exclusive marketing and distribution agreement to bring precision probiotic supplements Crescylia and EnteroSatys to the Colombian market.
EnteroSatys is pioneering precision probiotics thanks to its characterized mechanism of action at the molecular level: it increases satiety thanks to the protein ClpB produced by Hafnia alvei HA4597. ClpB naturally mimics the human satiety hormone alpha-MSH. The improved feeling of fullness helps with successful weight loss, as confirmed by a multicentric, randomized, double-blind placebo-controlled clinical study with 230 overweight adults, improving the success rate of the diet by almost 40%. This natural strain is a multi-awarded new, natural, safe, and effective weight management solution.
Crescylia is a formulation containing vitamin D3, acacia fiber, and precision probiotic LpWJL, with a characterized mechanism of action at the molecular level: it supports the absorption of protein thanks to the stimulation of peptidase gene expression and NOD2 activation. Its efficacy in growth was demonstrated in several preclinical studies in fruit flies and mice, including two published in Science.
This formulation was developed to support children’s growth and its main active, LpWJL, was elected best nutrition research project of the year 2021 by the internationally recognized NutraIngredients Awards.
Grégory Lambert, CEO of TargEDys:
“We are delighted to partner with Medical Foods to bring both Crescylia and EnteroSatys in Colombia. Like TargEDys, Medical Foods is a dynamic, young company aspiring to bring effective technological innovation to the benefit of patients and consumers. With the surge in obesity and overweight in Colombia, but also an 8,8% of undernutrition, medical nutrition is increasingly important, and this is where Medical Foods is leading the market.”
Mr. José Patiño , CEO of Medical Foods :
“We are very excited to partner with TargEDys and to welcome Crescylia and EnteroSatys to Colombia. Along with TargEDys, Medical Foods is committed to meeting the needs of the nutritional market, with innovative and specialized products, contributing to the well-being of the Colombian population in the face of the growing problems of obesity and metabolic health.”
About Medical Foods
Medical Foods SAS is a Colombian leading company in the development of innovative health products for functional nutrition and precision medicine. It is committed to transforming the lives of patients by translating the latest developments of science and medicine into products that can improve well being and overall health. Pioneers in making foods for special medical purposes for malnutrition and wound healing available in Colombia and now leading the way in supplements for modulating immune function, inflammation and metabolism.
More information at www.medicalfoods.com.co
About TargEDys® – “From Probiotics to PreciBiomics”
TargEDys® is a commercial-stage French biotech specialized in the development of nutraceutical solutions for the control of appetite through microbiome interventions. The company is the fruit of 20 years of research on the microbiota conducted within academic laboratories. The team developed and started the commercialization of a first product based on the precision probiotic strain Hafnia alvei HA4597™ which efficacy in weight and appetite has been clinically demonstrated. Targedys® develops a product portfolio focusing on overweight, undernutrition, and mental health, all based on the concept of PreciBiomic strains backed by a molecular mechanism of action and in vivo studies.
More information at www.targedys.com
Name: Nina Vinot
Job Title: Sales & Marketing Director
ReleaseLive, PR-Wirein, CE, Go Media, Google News, Reportedtimes, IPS, iCN Internal Distribution, Extended Distribution, English